Jun 21, 2019 - Pfizer (PFE) announces definitive deal buy Array BioPharma. Merck (MRK), Roche (RHHBY) and AstraZeneca (AZN) win approvals for new drugs/line extensions.
Jun 21, 2019 - We highlight a few leading players from the biotech sector, having surpassed the same so far in 2019 and are likely to put up a good show during the second half of 2019 as well.
Jun 19, 2019 - Zimmer Biomet (NYSE:ZBH) announces that EVP and Chief Financial Officer Daniel Florin will retire, effective July 1.Suketu Upadhyay has been appointed as the new CFO and comes on from his role as SVP,
Jun 19, 2019 - There has been a flurry of M&A deal announcements this year in the drug industry. Here we discuss three big drug/biotech companies, which may make the next M&A move.
Jun 19, 2019 - Bristol-Myers (BMY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Jun 18, 2019 - Top Analyst Reports for Broadcom, Amgen & NVIDIA
Jun 14, 2019 - These big pharma stocks all have a Zacks Rank #2 or better.
Jun 14, 2019 - Mallinckrodt (MNK) reports encouraging results from a phase IV study on Acthar for RA at the EULAR.
Jun 13, 2019 - Roche (RHHBY) announces positive data on rheumatic diseases drug, Rituxan, for pemphigus vulgaris.
Jun 12, 2019 - Roche (RHHBY) gets Priority Review status from the FDA for Rituxan in children with two rare blood vessel disorders.